Connect
MJA
MJA

Letters

Serotonin toxicity with therapeutic doses of dexamphetamine and venlafaxine

Felicity H Prior, Geoffrey K Isbister, Andrew H Dawson and Ian M Whyte

Med J Aust 2002; 176 (5): 240-241

Time for a grant category for curiosity-based research

Gordon L Ada and Frank Fenner

Med J Aust 2002; 176 (5): 244

Venlafaxine and bilateral acute angle closure glaucoma

Bradley Ng, G Mark C Sanbrook, Anthony J Malouf and Smita A Agarwal

Med J Aust 2002; 176 (5): 241

No obituary in "Death and Dying" issue

Paul B Harris

Med J Aust 2002; 176 (3): 196

SPHERE: A National Depression Project

Ian B Hickie, Tracey A Davenport, Elizabeth M Scott and Sharon L Naismith

Med J Aust 2002; 176 (4): 193-194

MEDicine or MADness

David C Currow

Med J Aust 2002; 176 (4): 190-191

No obituary in "Death and Dying" issue

Martin B Van Der Weyden

Med J Aust 2002; 176 (3): 196

EBM in action: Is laser treatment effective and safe for musculoskeletal pain?

Roberta Chow

Med J Aust 2002; 176 (4): 194-195

MEDicine or MADness

Roger W Hunt

Med J Aust 2002; 176 (4): 190-191

Evidence of human metapneumovirus in Australian children

Michael D Nissen, Ian M Mackay, Stephen J Withers, David J Siebert and Theo P Sloots

Med J Aust 2002; 176 (4): 188

EBM in action: Is laser treatment effective and safe for musculoskeletal pain?

Chris B Del Mar and Paul P Glasziou

Med J Aust 2002; 176 (4): 194-195

HIV among injecting drug users of Indo-Chinese ethnicity in Victoria

Jane S Hocking, Peter G Higgs, Cathy M Keenan and Nick Crofts

Med J Aust 2002; 176 (4): 191-192

Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis

James C Hurley

Med J Aust 2002; 176 (4): 188-189

Books as carriers of disease

Sir Keith Jones

Med J Aust 2002; 176 (4): 196

Detecting and reducing hospital adverse events: outcomes of the Wimmera clinical risk management program

Kathy M Brown, Humsha Naidoo and Arona E Offenberger

Med J Aust 2002; 176 (4): 192-193

Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis

Michael Whitby, Mary-Louise McLaws and Geoffrey Berry

Med J Aust 2002; 176 (4): 188-189

Detecting and reducing hospital adverse events: outcomes of the Wimmera clinical risk management program

Alan M Wolff, Jo Bourke, lan A Campbell and David W Leembruggen

Med J Aust 2002; 176 (4): 192-193

PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension

Ben D Ewald and Brita A Pekarsky

Med J Aust 2002; 176 (4): 189-190

SPHERE: A National Depression Project

Nicole Phillips, Michael J Oldmeadow and Natalie Krapivensky

Med J Aust 2002; 176 (4): 193-194

PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension

Mark R Nelson, John J McNeil, Anna Peeters, Henry Krum and Christopher M Reid

Med J Aust 2002; 176 (4): 189-190

Epidemiological modelling (including economic modelling) and its role in preventive drug therapy

Kent R Johnson and Marissa N Lassere

Med J Aust 2002; 178 (4): 188-189

Ethics and evidence-based medicine

Simon R Tomlinson, Kerry J Breen, Malcolm H Parker, Chris B Del Mar, Paul P Glasziou, Lucie Rychetnik and and Stephen R Leeder

Med J Aust 2002; 176 (3): 137-139

Ethics and evidence-based medicine

Simon R Tomlinson, Kerry J Breen, Malcolm H Parker, Chris B Del Mar, Paul P Glasziou, Lucie Rychetnik and Stephen R Leeder

Med J Aust 2002; 176 (3): 137-139

Ethics and evidence-based medicine

Simon R Tomlinson

Med J Aust 2002; 176 (3): 137-139

Carotid stenting — current caution

Peter L Field

Med J Aust 2002; 176 (3): 135